News

AGC Bio Expands pDNA and mRNA Manufacturing Capacity at Heidelberg Facility

AGC Biologics today announced expansion plans for the company’s Heidelberg facility to increase manufacturing capacities for plasmid-DNA (pDNA) and messenger RNA (mRNA) projects. 

Follow Us
Join us on LinkedIn Follow us on Twitter